Drugs

Patent Manipulation Keeps Insulin Prices High

By Haley Weiss

RSV Vaccines Must Go to the Right People

By Elisabeth Rosenthal

Pfizer Shares Drop As Obesity Drug Halted Over Safety Fears

By Matthew Griffin / Bloomberg

More Effective Weight Loss Drugs Are Coming

By Alice Park
More in Drugs

A New Alzheimer's Drug Is One Step Closer to Full Approval

But access remains a problem.

By Alice Park

FDA Advisers Vote in Favor of Infant RSV Drug

The panel voted unanimously to endorse the long-acting monoclonal antibody Beyfortus for newborns and infants.

By Suzi Ring and Ilena Peng/Bloomberg

Teens Are Taking Wegovy for Weight Loss

The drug promises potentially dramatic benefits for teenagers with obesity. But doctors are still learning about it.

By Jamie Ducharme

Why Mounjaro Works So Well for Weight Loss

The drug is currently being reviewed by the FDA for weight loss.

By Alice Park

FDA Approves New RSV Vaccine for Older Adults

Pfizer's new shot for seniors becomes the second RSV vaccine in the world.

By Alice Park

New Weight-Loss Pill Found to Be Effective

Novo Nordisk's weight-loss drug semaglutide, sold as the weekly Wegovy shot, was effective as a daily pill in a study.

By Naomi Kresge/Bloomberg

Pfizer’s RSV Vaccine for Pregnant Women Wins FDA Panel Support

All 14 members of the FDA advisory committee recommended the vaccine as effective for protecting newborns from RSV.

By Nacha Cattan/Bloomberg

Inside the Emerging Xylazine Addiction Crisis

One woman, who became unknowingly addicted to the drug, called life on it pure “survival mode."

By Anisha Kohli / Philadelphia

Drugs Like Adderall Can Be Prescribed Online Into 2024

U.S. health and drug officials reversed their earlier position that restrictions on the drugs would be reinstated as the pandemic eased.

By Ike Swetlitz and Ganny Belloni/Bloomberg

Conservatives Are Changing Stances on Fentanyl Test Strips

Fentanyl test strips are often regarded as a “low-cost, high-impact” harm-reduction strategy

By Anisha Kohli

Why It Took So Long to Get an RSV Vaccine

After years of failures, the first vaccine was approved, and more are coming.

By Alice Park

Eli Lilly's Alzheimer's Drug Shows Greatest Benefit Yet

Donanemab slowed cognitive decline in people with early Alzheimer’s disease by 35%, according to the company.

By Alice Park

FDA Approves First Pill for the Microbiome

The therapy opens the door to future treatments that may restore healthy bacteria in the body.

By Alice Park

FDA Approves Drug to Treat Rare Form of ALS

Biogen's drug, Qalsody, was cleared through an accelerated approval pathway, meaning more research is needed for it to stay on the market.

By Fiona Rutherford and Robert Langreth/Bloomberg

Why the Adderall Shortage Has Lasted So Long

Ending a drug shortage is more complex than it seems.

By Jamie Ducharme

The Latest Promising Long COVID Treatment? Psychedelic Drugs

Scientists are studying whether psychedelics, like psilocybin and MDMA, could help treat Long COVID symptoms.

By Jamie Ducharme
More from TIME
More From TIME